Chemotherapy in oesophageal cancer

Cancer Treatment Reviews

Volumn 23, Issue 2, 1997, Pages 65-85

  Kok, T C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; BLEOMYCIN; CISPLATIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; ISOTRETINOIN; METHOTREXATE; MITOGUAZONE; MITOMYCIN C; NAVELBINE; PACLITAXEL; VINDESINE;

ADENOCARCINOMA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; RADIATION DOSE; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 0030791024     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(97)90021-9     Document Type: Review

References (188)

1. Parkin D. M., Laara, E. & Muir, C. S. (1988) Estimates of the world-wide frequency of sixteen major cancers in 1980. Int. J. Cancer 41: 184-197.
2. Sales, D. & Levin, B. (1985) Incidence, epidemiology, and predisposing factors. In: DeMeester, T. R. & Levin, B., eds, Cancer of the Esophagus. New York: Grune and Stratton, pp. 1-19.
3. Kmet, J. & Mahboubi, E. (1972) Esophageal cancer in the Caspian Littoral of Iran: initial studies. Science 175: 846-853.
4. Magee, P. N. & Barnes, J. M. (1967) Carcinogenic nitroso compounds. Adv. Cancer Res. 10: 163-246.
5. Craddock, V. M. (1993) Chemicals carcinogenic for the oesophagus: the nitrosamines. In: Cancer of the Esophagus. Cambridge, Cambridge University Press, pp. 69-116.
6. Tuyns, A. J., Pequignot, G. & Abbatucci, J. S. (1979) Oesophageal cancer and alcohol consumption: importance of type of beverage. Int. J. Cancer 23: 443-447.
7. La Vecchia, C. & Negri, E. (1989) The role of alcohol in esophageal cancer in non-smokers, and of tobacco in non-drinkers. Int. J. Cancer 43: 784-785.
8. Tuyns, A. J. (1983) Esophageal cancer in non-smoking drinkers and in non-drinking smokers. Int. J. Cancer 32: 443-444.
9. Pottern, L. M., Morris, L E., Blot, J., Ziegler, R. G. & Fraumeni, J. F. (1981) Esophageal cancer among black men in Washington DC. I. Alcohol, tobacco, and other risk factors. J. Natl. Cancer Inst. 67: 777-783.
10. Picheral, H. France. In: Howe, G. M. (ed.). Global Geocancerology, A World Geography of Human Cancers. pp 144-153. Edinburgh, Churchill Livingstone.
11. Southon, S., Livesey, G., Gee, J. M. & Johnson, I. T. (1985) Intestinal cellular proliferation and protein synthesis in zinc-deficient rats. Br. J. Nutr. 53: 595-603.
12. Winkler, B., Capo, V., Reumann, W. et al. (1985) Human papillomavirus infection of the esophagus. Cancer 55: 149-155.
13. Hille, J. J., Margolius, K. A., Markowitz, S. & Isaacson, C. (1986) Human papillomavirus infection related to oesophageal carcinoma in black South Africans. S. Afr. Med. J. 69: 417-420.
14. Kok, T. C., Nooter, K., Tjong-A-Hung, S. P., Smits, H. L, & ter Schegget, J. (1997) No evidence of human papillomavirus in squamous cell cancer of the esophagus in a low risk area. Eur. J. Cancer (in press).
15. Suzuk, L., Noffsinger, A. E., Zong Hui, Y. & Fenoglio-Preiser, C. M. (1996) Detection of human papillomavirus in esophageal squamous cell carcinoma. Cancer 78: 704-710.
16. Blot, W. J., Devesa, S. S., Kneller, R. W. & Fraumeni, J. F. (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J.A.M.A. 265: 1287-1289.
17. Powell, J. & McConkey, C. C. (1991) Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br. J. Cancer 62: 440-443.
18. MacDonald, W. C. & MacDonald, J. B. (1987) Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 60: 1094-1098.
19. Haggitt, R. C. (1992) Adenocarcinoma in Barrett's esophagus: A new epidemic? Hum. Pathol 23: 475-476.
20. Wright, T. A., Gray, M. R., Morris, A. I. et al. (1996) Cost effectiveness of detecting Barrett's cancer. Gut 39: 574-579.
21. Blot, W. J. (1994) Esophageal cancer trends and risk factors. Sem. Oncol 4: 403-410.
22. Byers, T. & Graham, S. (1984) Epidemiology of diet and cancer. Adv. Cancer Res. 41: 1-69.
23. Tuyns, A. J., Riboli, E. & Doornbos, G. (1985) Nutrition and cancer of the esophagus. In: Joossens, J. V., Hill, M. J. & Geboers, J. (eds). Diet and Human Carcinogenesis pp 71-79. Amsterdam, Excerpta Medica.
24. Craddock, V. M. (1993) Cancer of the esophagus; Approaches to the Etiology. Cambridge, Cambridge University Press.
25. Tsang, W. Y. M., Chan, J. K. C., Lee, K. C., Lee, K. C., Leung A. K. & Fu, Y. T. (1991) Basaloid-squamous carcinoma of the upper aerodigestive tract and so-called adenoid cystic carcinoma of the oesophagus; the same tumour type? Histopathol. 19: 35-46.
26. Hippeläinen, M., Eskelinen, M., Lipponen, P., Chang, F. & Syrjänen, K. (1993) Mitotic activity index, volume corrected mitotic activity index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. Anticancer Res. 13: 677-682.
27. Hermaneck, P. & Sobin, L. H. (eds.) (1992) TNM Classification of Malignant Tumors. International Union Against Cancer. Fourth Edition, 2nd Revision pp 42-44. Berlin, Springer-Verlag.
28. Tio, T. L., Coene, P. P. L. O., den Hartog Jager, F. C. A. & Tytgat, G. N. J. (1990) Preoperative TNM classification of esophageal carcinoma by endosonography. Hepato-gastroenterol. 37: 376-381.
29. Hordijk, M. L., Zander, H., Van Blankenstein, M. & Tilanus, H. W. (1993) Influence of tumor stenosis on the accuracy of endosonography in preoperative T staging of esophageal cancer. Endoscopy25: 171-175.
30. Van Overhagen, H., Lameris, J. S., Zonderland, H. N., Tilanus, H. W., Van Pel, R. & Schütte, H. E. (1991) Ultrasound and ultrasound-guided fine needle biopsy of supraclavicular lymph nodes in patients with esophageal carcinoma. Cancer 67: 585-587.
31. Van Overhagen, H., Lameris, J. S., Berger, M. Y. et al. (1993) Improved assessment of supraclavicular and abdominal metastases in oesophageal and gastro-oesophageal junction carcinoma with the combination of ultrasound and computed tomography. Br. J. Radiol. 66: 203-208.
32. Van Overhagen, H., Berger, M. Y, Meijers, H. et al. (1993) Influence of radiologically and cytologically assessed distant metastases on the survival of patients with esophageal and gastroestophageal junction carcinoma. Cancer 72: 25-31.
33. Orringer, M. B., Marshall, B. & Stirling M. C. (1993) Transhiatal esophagectomy for benign and malignant disease. Cardiovasc. Surg. 105: 265-277.
34. Lozac'h, P., Topart, F., Etienne, J. & Charles, J. F. (1991) Ivor Lewis operation for epidermoid carcinoma of the esophagagus. Ann. Thorac. Surg. 52: 1154-1157.
35. Müller, J. M., Erasmi, H., Stelzner, M., Zieren, U. & Pichlmaier, H. (1990) Surgical therapy of oesophageal carcinoma. Br. J. Surg. 77: 849-857.
36. Roth, J. A. & Putnam Jr, J. B. (1994) Surgery for cancer of the esophagus. Sem. Oncol. 21: 453-461.
37. Herskovic, A., Martz, K., Al-Sarraf, M. et al. (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med. 326: 1593-1598.
38. Nakajima, T., Fukuda, H., Hosono, M. et al. (1992) Intraluminal irradiation for T2M0 esophageal cancer: effect of patient selection on prognosis. Radiat. Med. 10: 123-128.
39. Clifton, E. E., Goodner, J. T., & Bronstein, E. L. (1960) Preoperative irradiation for cancer of the esophagus. Cancer 13: 37-45.
40. Parker, E. F., & Gregorie, H. B. (1976) Carcinoma of the esophagus. J.A.M.A. 235: 1018-1020.
41. Nakayama, K., & Kinoshita, Y. (1974) Surgical treatment combined with preoperative concentrated irradiation. J.A.M.A. 227: 178-181.
42. Marks, R. D., Scruggs, H. J. & Wallace, K. M. (1976) Preoperative radiation therapy for carcinoma of the esophagus. Cancer 38: 84-89.
43. Van Andel, J. G., Dees, J., Dijkhuis, C. et al. (1979) Carcinoma of the esophagus: Results of treatment. Ann. Surg. 190: 684-689.
44. Launois, B., DeLarue, D., Campion, J. P. & Kerbaol, M. (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg. Gynecol. Obstet. 153: 690-692.
45. Arnott, S. J., Duncan, W., Kerr, G. R. et al. (1992) Low dose preoperative radiotherapy for carcinoma of the esophagus: Results of a randomized clinical trial. Radiother. Oncol. 24: 108-113.
46. Wang, M., Gu, X. Z., Yin, W. B., Huang, L. J. & Zhang, D. W. (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: Report on 206 patients. Int. J. Radiat. Oncol. Biol. Phys. 16: 325-327.
47. Fraser, R. W., Wara, W. M., Thomas, A. N. et al. (1978) Combined treatment methods for carcinoma of the esophagus. Radiology 128: 461-465.
48. Goodner, J. T. (1969) Surgical and radiation treatment of cancer of the thoracic esophagus. Am. J. Roentgenol. Radium Ther. Ther. Nucl. Med. 105: 523-528.
49. Fok, M., Sham, J. S. T., Choy, D., Cheng, S. W. K. & Wong, J. (1993) Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled study. Surgery 113: 138-147.
50. Bosch, A., Frias, Z., Caldwell, W. L. & Jaeschke, W. H. (1979) Autopsy findings in carcinoma of the esophagus. Acta Radiologica Oncol. 18: 103-112.
51. Mandard, A. M., Chasle, J., Marnay, B. et al. (1981) Autopsy findings in 111 cases of esophageal cancer. Cancer 48: 329-335.
52. Anderson, L. L. & Lad, T. E. (1982) Autopsy findings in squamous-cell carcinoma of the esophagus. Cancer 50: 1587-1590.
53. Kelsen, D., Lovett, D., Wong, J. et al. (1992) Interferon alfa-2a and Fluorouracil in the treatment of patients with advanced esophageal cancer. J. Clin. Oncol. 10: 269-274.
54. Darnton, S. J., Allen, S. M., Edwards, C. W. & Matthews, H. R. (1993) Histopathological findings in oesophageal carcinoma with and without preoperative chemotherapy. J. Clin. Pathol. 46: 51-55.
55. Ajani, J. A., Ilson, D. H., Daugherty, K., Pazdur, R., Lynch, P. M. & Kelsen, D. P. (1994) Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J. Nat. Cancer Inst. 86: 1086-1091.
56. Ilson, D. H., Sirott, M., Saltz, L. et al. (1995) A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer 75: 2197-2202.
57. Bhansali, M. S., Vaidya, J. S., Bhatt, R. G., Patil, P. K., Badwe, R.A. & Desai, P. (1996) Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical controls. Ann. Oncol. 7: 355-359.
58. Blazeby, J. M., Williams, M. H., Brookes, S. T., Alderson, D. & Farndon, J. R. (1995) Quality of life measurement in patients with oesophageal cancer. Gut 37: 505-508.
59. Kelsen, D. P., Heelan, R., Coonley, C. et al. (1983) Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma. Am. J. Clin. Oncol. 6: 539-546.
60. Kolaric, K., Maricic, Z., Dujmovic I. & Roth, A. (1976) Therapy of advanced esophageal cancer with bleomycin, irradiation and combination bleomycin and irradiation. Tumori 62: 255-262.
61. Agha, F. P., Gennis, M. A., Orringer, M. B. & Forastiere, F. (1986) Evaluation of response to preoperative chemotherapy in esophageal and gastric cardia cancer using biphasic esophagrams and surgical-pathologic correlation. Am. J. Clin. Oncol. 3: 227-232.
62. Conroy, T. (1993) Measurement of the primary esophageal tumor. In: Wils, J., Bleiberg, H., Duez, N. (eds.) Manual for Diagnosis and Treatment of Gastrointestinal Tract Cancer, pp. 28-33. Bruxelles, EORTC GITCG.
63. Hordijk, M. L., Kok, T. C., Wilson, J. H. P. & Mulder, A. H. (1993) Assessment of response of esophageal carcinoma to induction chemotherapy. Endoscopy 9: 592-596.
64. Roubein, L. D., Dubrow, R., David, C. et al. (1993) Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction. Endoscopy 9: 587-591.
65. Hordijk, M. L. (1995) Restaging after radiotherapy and chemotherapy: value of endoscopic ultrasonography. Gastrointest. Endosc. Clin. N. Am. 3: 601-608.
66. Ajani, J. A., Roth, J. A., Ryan, B. et al. (1990) Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J. Clin. Oncol. 7: 1231-1238.
67. Kelsen, D. (1984) Chemotherapy of esophageal cancer. Sem. Oncol. 2: 159-168.
68. Leichman, L. & Berry, B. T. (1991) Experience with cisplatin in treatment regimens for esophageal cancer. Sem. Oncol. 1 (Suppl. 3): 64-72.
69. Ajani, J. A. (1994) Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Sem. Oncol. 4: 474-482.
70. Edzinli, E. Z., Gelber, R., Desai, D. V., Falkson, G., Moertel, C. G. & Hahn, R. G. (1980) Chemotherapy of advanced esophageal carcinoma. Cancer 46: 2149-2153.
71. Advani, S. H., Saikia, T. K., Swaroop, S. et al. (1985) Anterior chemotherapy in esophageal cancer. Cancer 56: 1502-1506.
72. Bonadonna, G., de Lena, M., Monfardini, S. et al. (1972) Clinical trial with bleomycin in lymphomas and in solid tumors. Eur. J. Cancer 8: 205-215.
73. Ravry, M., Moertel, C. G., Schutt, A. J., Hahn, R. G. & Reitemeier, R. J. (1973) Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066). Cancer Chemoth. Rep. 4: 493-495.
74. Tancini, G., Bajetta, E. & Bonadonna, G. (1974) Terapia con bleomycin da sola o in associazione con methotrexate nel carcinoma epidermoide dell' esofago. Tumori 60: 65-71.
75. Davis, S., Shanmugathasa, M. & Kessler, W. (1980) cis-Dichlorodiammineplatinum(II) in the treatment of esophageal carcinoma. Cancer. Treat. Rep. 64: 709-711.
76. Engstrom, P. F., Lavin, P. T. & Klaasen, D. J. (1983) Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat. Rep. 78: 713-715.
77. Pannetiere, F. J., Leichman, L. P., Tilchen, E. J. & Chen, T. T. (1984) Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group Study. Cancer Treat. Rep. 78: 1023-1024.
78. Ravry, M. J. R., Moore, M. R., Omura, G. A., Esseese, I. & Bartolucci, A. (1985) Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial. Cancer Treat. Rep. 12: 1457-1458.
79. Bleiberg, H., Jacob, J. H., Bedenne, L. Paillot, B., De Besi, P. & Lacave, A., for the EORTC G.I. Tract Cancer Cooperative Group. (1991) Randomized phase II trial of 5-fluoro-uracil (5FU) and cisplatin (DDP) versus DDP alone in advanced oesophageal cancer. Proc. Ann. Meet. Amer. Soc. Clin. Oncol. 10: A447.
80. Coonley, C. J., Bains, M., Heelan, R., Dukeman, M. & Kelsen, D. P. (1983) Phase II study of etoposide in the treatment of esophageal carcinoma. Cancer Treat. Rep. 67: 397-398.
81. Harstrick, A., Bokemeyer, C., Preusser, P. et al. (1992) Phase II study of single agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus. Cancer Chemother. Pharmacol. 29: 321-322.
82. Lokich, J. J., Shea, M. & Chaffey, J. (1987) Sequential infusional 5-fluorouracil followed by concommitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer 60: 275-279.
83. Kok, T. C., van der Gaast, A. & Splinter, T. A. W. (1996) 5-Fluorouracil and folinic acid in advanced adenocarcinoma of the esophagus or esophago-gastric junction area. Ann. Oncol. 7: 533-534.
84. Falkson, G. (1971) Methyl-GAG (NSC-32946) in the treatment of esophagus cancer. Cancer Chemother. Rep. 55: 209-212.
85. Kelsen, D., Chapman, R., Bains, M., Heelan, R., Dukeman, M. & Golbey, R. (1982) Phase II Study of Methyl-GAG in the treatment of esophageal carcinoma. Cancer Treatm. Rep. 6: 1427-1429.
86. Ravry, M. J. R., Omura, G. A., Hill, G. J., Bartolucci, A. A. & Velez-Garcia, E. (1986) Phase II evaluation of mitoguazone in cancer of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group trial. Cancer Treat. Rep. 70: 533-534.
87. Coia, L R. (1993) The use of mitomycin in esophageal cancer. Oncology 50 (Suppl. 1): 53-60.
88. Kelsen, D. P., Bains, M., Cvitkovic, E. & Golbey, R. (1979) Vindesine in the treatment of esophageal carcinoma: a phase 2 study. Cancer Treatm. Rep. 63: 2019-2021.
89. Bedikian, A. Y., Valdivieso, M., Bodey, G. P. & Freireich, E. J. (1979) Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors. Cancer Chemother. Pharmacol. 2: 263-266.
90. Bezwoda, W. R., Derman, D. P., Weaving, A. & Nissenbaum, M. (1984) Treatment of esophageal cancer with vindesine: an open trial. Cancer Treat. Rep. 68: 783-785.
91. Iizuka, T., Kakegawa, T., Ide, H. et al. (1989) A phase II study of vindesine in the treatment of esophageal carcinoma. Jpn. J. Clin. Oncol. 19: 380-383.
92. Conroy, T., Etienne, P.-L., Adenis, A. et al. for the E.O.R.T.C. Gastrointestinal Tract Cancer Cooperative Group. (1996) Phase II trial of Vinorelbine in metastatic squamous cell esophageal carcinoma. J. Clin. Oncol. 14: 164-170.
93. Murthy, S. K., Prabhakaran, P. S., Chandrashekar, M., Deshpande, R., Doval, D. C. & Gopinath, K. S. (1990) Neoadjuvant cis-DDP in esophageal cancers: an experience at a regional cancer centre, India. J. Surg. Oncol. 45: 173-176.
94. Sternberg, C, Kelsen, D., Dukeman, M., Leichman, L. & Heelan, R. (1985) Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus. Cancer Treat. Rep. 69: 1305-1307.
95. Steel, A., Cullen, M. H., Robertson, P. W. & Matthews, H. R. (1988) A phase II study of carboplatin in adenocarcinoma of the esophagus. Br. J. Cancer 58: 500-501.
96. Mannell, A. & Winters, Z. (1989) Carboplatin in the treatment of esophageal cancer. S. Afr. Med. J. 76: 213-214.
97. Queisser, W., Preusser, P., Mross, K. B. et al. (1990) Phase II evaluation of carboplatin in advanced esophageal carcinoma. Onkologie 13: 190-193.
98. Armand, J. P., Cappelaere, P., Guichet, N. et al. (1987) A phase II study of iproplatin (CHIP) in untreated advanced epidermoid cancer using a 5 daily iv schedule. Proc. Ann. Meet. Am. Ass. Cancer Res. 214: A850.
99. Cappelaere, P., Guiochet, N., Bastit, Ph. et al. (1993) Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung. Eur. J. Cancer 29A: 1216.
100. Favre, R., Rinaldi, Y. & Carcassonne, Y (1987) Les anthracyclines dans le traitement des cancers épidermoïdes: col utérin, œsophage, bronches, tête et cou. Path. Biol. Paris 35: 111-117.
101. Kac, J., Spielmann, M., Guillot, T. et al. (1991) Phase II study of 4′ epirubicin in advanced squamous cell oesophageal cancer. Proc. Ann. Meet. Am. Soc. Clin. Oncol. 10: A491.
102. Margolin, K., Doroshow, J., Leong, L. et al. (1989) (1989) Combination chemotherapy with cytosine arabinoside (Ara-C) and cis-diamminedichloroplatinum (CDDP) for squamous cancers of the upper aerodigestive tract. Am. J. Clin. Oncol. 12: 494-497.
103. Ajani, J. A., Roth, J. A., Putnam, J. B. et al. (1995) Feasibility of five courses of preoperative chemotherapy in patients with resectable adenocarcinoma of the esophagus or gastroesophageal junction. Eur. J. Cancer 31A: 665-670.
104. Kelsen, D. P., Cvitkovic, E., Bains, M. et al. (1978) Cis-dichlorodiammineplatinum (II) and bleomycin in the treatment of esophageal carcinomas. Cancer Treat. Rep. 62: 1042-1046.
105. Coonley, C. J., Bains, M., Hilaris, B., Chapman, R. & Kelsen, D. P. (1984) Cisplatin and bleomycin in the treatment of esophageal carcinoma. Cancer 54: 2351-2359.
106. Marcuello, E., Alba, G., Gomez De Segura, G. et al. (1988) Cisplatin and intravenous continuous infusion of bleomycin in advanced and metastatic esophageal cancer. Eur. J. Cancer Clin. Oncol. 24: 633-635.
107. Vogl, S. T., Greenwald, E. & Kaplan, B. H. (1981) Effective chemotherapy for esophageal cancer with metheotraxate, bleomycin, and cis-diamminedichloroplatinum II. Cancer 48: 2555-2558.
108. De Besi, P., Salvagno, L., Endrizzi, L. et al. (1984) Cisplatin, bleomycin and methotrexate in the treatment of advanced oesophageal cancer. Eur. J. Cancer Clin. Oncol. 20: 743-747.
109. Vogl, S. E., Camacho, F., Berenzweig, M. & Ruckdeschel, J. (1985) Chemotherapy for esophageal cancer with mitoguazone, methotrexate, bleomycin and cisplatin. Cancer Treat. Rep. 69: 21-23.
110. Kelsen, D., Hilaris, B., Coonley, C. et al. (1983) Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am. J. Med. 75: 645-653.
111. Dinwoodie, W. R., Bartolucci, A. A., Lyman, G. H. et al. (1986) Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group trial. Cancer Treat. Rep. 70: 267-270.
112. Roth, J. A., Pass, H. I., Flanagan, M. M., Graeber, G. M., Rosenberg, J. C. & Steinberg, S. (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J. Thorac. Cardiovasc. Surg. 96: 242-248.
113. Kelsen, D. P., Minsky, B., Smith, M. et al. (1990) Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. J. Clin. Oncol. 8: 1352-1361.
114. Spielman, M., Guillot, T., Kac, J. et al. (1989) Phase II trial of cisplatin and continuous infusion of bleomycin and 5-fluorouracil in advanced esophageal cancer. Proc. Ann. Meet. Amer. Soc. Clin. Oncol. 8: A393.
115. Iizuka, T., Kakegawa, T., Ida, H., Ando, N., Watanabe, H. & Takagi, I. (1991) Phase II evaluation of combined cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus: Japanese Esophageal Oncology Group trial. Jpn. J. Clin. Oncol. 21: 176-179.
116. Kelsen, D. P., Coonley, C., Heelan, R. & Bains, M. (1986) Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer. Cancer Treat. Rep. 70: 255-259.
117. Chapman, R., Fleming, T. R., Van Damme, J. & Macdonald, J. (1987) Cisplatin, vinblastine, and mitoguazone in squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study. Cancer Treat. Rep. 71: 1185-1187.
118. Forastiere, A. A., Gennis, M., Orringer, M. B. & Agha, F. P. (1987) Cisplatin, vinblastine, and mitoguazone chemotherapy for epidermoid and adenocarcinoma of the esophagus. J. Clin. Oncol. 5: 1143-1149.
119. Desai, P. B., Advani, S. H., Dinshaw, K. A. et al. (1986) The long term impact of front-loading chemotherapy in advanced esophageal cancers - a report of 88 patients treated with cisplatin-methotrexate. Colloq. Inser. 137: 653-659.
120. Saikia, T. K., Advani, S. H., Ramakrishnan, G., Swaroop, S., Sharma, S. & Desai, P. B. (1989) Intermediate-dose methotrexate and cisplatin in the treatment of advanced epidermoid esophageal carcinoma. Cancer 64: 371-373.
121. Resbeut, M., Le Prise-Fleury, E., Ben-Hassel, M. et al. (1985) Squamous cell carcinoma of the esophagus. Treatment by combined vincristine-methotrexate plus folinic acid rescue and cisplatin before radiotherapy. Cancer 56: 1246-1250.
122. Lokich, J., Moore, C., Bern, M. & Zipoli, T. (1990) Infusional etopiside and cisplatinum with and without floxuridine in gastroesophageal cancer. Proc. Ann. Meet. Am. Soc. Clin. Oncol. 9: A492.
123. Kok, T. C., Van der Gaast, A., Dees, J. et al. (1996) Cisplatin and etoposide in oesophageal cancer: a phase II study. Br. J. Cancer 74: 908-984.
124. Ajani, J. A., Roth, J. A., Bernadette Ryan, M. et al. (1993) Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junction. J. Clin. Oncol. 11: 22-28.
125. Allen, S. M., Duffy, J. P., Walker, S. J., Darnton, S. J., Cullen, M. H. & Matthews, H. R. (1994) A phase II study of mitomycin, ifosfamide, and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus. Clin. Oncol. 6: 91-95.
126. De Besi, P., Sileni, V. C., Salvagno, L. et al. (1996) Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer. Cancer Treat. Rep. 70: 909-910.
127. Hilgenberg, D., Carey, R. W., Wilkins, W. W., Choi, N. C. & Mathisen, D. J. (1988) Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann. Thorac. Surg. 45: 357-363.
128. Iizuka, T., Kakegawa, T., Ide, H. et al. (1992) Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. J. Clin. Oncol. 22: 172-176.
129. Mercke, C., Albertsson, M., Hambraeus, G. et al. (1991) Cisplatin and 5-FU combined with radiotherapy and surgery in the treatment of squamous cell carcinoma of the esophagus. Acta Oncol. 30: 617-622.
130. Ajani, J. A., Ryan, B., Rich, T. A. et al. (1992) (1992) Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur. J. Cancer 28A: 880-884.
131. Charlois, T., Burtin, P., Kader Ben Bouali, A., Person, B., Ferrero, P., Delaby, J. & Boyer, J. (1992) Facteurs prédictifs de réponse à la chimiothérapie du cancer épidermoïde de l'œsophage. Gastroenterol. Clin. Biol. 16: 134-140.
132. Gisselbrecht, C., Calvo, F., Mignot, L. et al. (1983) Flourouracil, adriamycin, and cisplatin: combination chemotherapy of advanced esophageal carcinoma. Cancer 52: 974-979.
133. Bamias, A., Hill, M. E., Cunningham, D. et al. (1996) Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma. Cancer 77: 1978-1985.
134. Preusser, P., Wilke, H., Achterrath, W. et al. (1988) Disease oriented phase II study with cisplatin (P), etoposide (E) and 5-fluorouracil (F)=PEF in advanced squamous cell carcinoma of the esophagus. Proc. Ann. Meet. Am. Soc. Clin. Oncol. 7: A388.
135. Stahl, M., Wilke, H., Meyer, H.-J. et al. (1994) 5-Flourouracil, folinic acid, etoposide and cisplatin chemotherapy of the oesophagus. Eur. J. Cancer 3: 325-328.
136. Temeck, B. K., Liebmann, J. E., Theodoissiou, C. et al. (1996) Phase II trial of 5-fluourouracil, leucovorin, interferon-α-2A, and cisplatin as neoadjuvant chemotherapy for localized advanced esophageal carcinoma. Cancer 77: 2432-2439.
137. Wadler, S., Haynes, H., Beitler, J. J. et al. (1996) Phase II clinical trial with 5-fluourouracil, recombinant interferon-α +(Combining comma above sign)-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. Cancer 78: 30-34.
138. Javed, T., Reed, C., Walle, T., Stuart, R. K., Ibrado, A. M. & Bhalla, K. (1995) A regimen of paclitaxel, cisplatin and 5-fluourouracil followed by G-CSF is highly active against epidermoid and adenocarcinoma of the esophagus. Proc. Ann. Meet. Am. Soc. Clin. Oncol. 14: A456.
139. Wadler, S., Fell, S., Haynes, H. et al. (1993) Treatment of carcinoma of the esophagus with 5-flourouracil and recombinant alfa-2A-interferon. Cancer 71: 1726-1730.
140. Ilson, D. H., Kelsen, D. P., Saltz, L. & Martin, L. (1995) A phase II trial of interferon-alpha 2A and 13-cis-retinoic acid in esophageal carcinoma: no activity in adenocarcinoma. Proc. Ann. Meet. Am. Soc. Clin. Oncol. 14: A476.
141. Kok, T. C., Van der Gaast, A. & Splinter, T. A. W. (1997) 13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the esophagus. Eur. J. Cancer 33: 165-166.
142. Muggia, F. M. & Gill, I. (1990) Primary Chemotherapy. In: DeVita, V. T. Jr., Hellman, S. and Rosenberg, S. A. (eds) Cancer: principles & practice of oncology updates. Philadelphia, PA: Lippincott, pp. 1-12.
143. Harris, D. T. & Mastrangelo, M. J. (1991) Theory and application of early systemic therapy. Sem. Oncol. 18: 493-503.
144. Schatten, W. E. (1958) An experimental study of postoperative tumor metastases I. Growth of pulmonary metastases following total removal of primary leg tumor. Cancer 11: 455-459.
145. Simpson-Herren, L., Sandford, A. H. & Holmquist, J. P. (1976) Effects of surgery on the cell kinetics of residual tumor. Cancer Treat. Rep. 60: 1749-1760.
146. Fisher, B., Gunduz, N. & Saffer, E. A. (1983) Influence of the interval between primary tumour removal and chemotherapy on kinetics and growth of metastases. Cancer Res. 43: 1488-1492.
147. Pendergast, W. J. Jr., Drake, W. P. & Mardiney, M. R. Jr. (1976) A proper sequence for the treatment of B16 melanoma: chemotherapy, surgery and immunotherapy. J. Natl. Cancer Inst. 57: 539-544.
148. Vignoud, J., Visset, J., Paineau, J., Le Neel, J. C., Cuilliere, P. & Cussac, A. (1990) Preoperative chemotherapy in squamous cell carcinoma of the esophagus: clinical and pathological analysis, 48 cases. Ann. Oncol. 1 (Suppl.): 45.
149. Kies, M. S., Rosen, S. T., Tsang, T. K. et al. (1987) Cisplatin and 5-flouro-uracil in the primary management of squamous esophageal cancer. Cancer 60: 2156-2160.
150. Schlag, P. (1992) Randomisierte Studie zur präoperativen Chemotherapie beim Plattenepithelcarcinom des Oesophagus. Chirurg 63: 709-714.
151. Nygaard, K., Hagen, S., Hansen, H. S. et al. (1992) Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J. Surg. 16: 1104-1109.
152. Fok, M., Law, W. & Wong, J. (1995) Prospective randomised study on preoperative chemotherapy for resectable intrathoracic squamous cancer of the oesophagus. Abstracts volume, 6th World Congress of the Int. Soc. Dis. Esoph. Milan, Italy, 23-26 August, p. 139.
153. Kok, T. C., Tilanus, H. W., Lanschot van, J., Siersema, P. D., Overhagen van, H. & Bosman, F. (1995) Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: a 3rd interim report. Abstracts volume, 6th World Congress of the Int. Soc. Dis. Esoph. Milan, Italy, 23-27 August, p. 139.
154. Steel, G. G. (1988) The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radioth. Oncol. 11: 31-35.
155. Steel, G. G. & Peckham, M. J. (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int. J. Radiat. Oncol. Biol. Phys. 5: 85-91.
156. Byfield, J. E., Barone, R., Mendelsohn, J. et al. (1980) Infusional 5-fluourouracil and X-ray therapy for non-resectable esophageal cancer. Cancer 45: 703-708.
157. Earle, J. D., Gelber, R. D., Moertel, C. G. and Hahn, R. G. (1980) A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int. J. Radiat. Oncol. Biol. Phys. 6: 821-826.
158. Kolarić, K., Maričić, Ž., Roth, A. & Dujmović, I. (180) Combination of bleomycin and adriamycin with and without radiation in the treatment of inoperable esophageal cancer. Cancer 45: 2265-2273.
159. Franklin, R., Steiger, Z., Vaishampayan, G. et al. (1983) Combined modality therapy for esophageal squamous cell carcinoma. Cancer 51: 1062-1071.
160. Leichman, L., Steiger, Z., Seydel, H. G. et al. (1984) Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J. Clin. Oncol. 2: 75-79.
161. Popp, M. B., Hawley, D., Reising, J. et al. (1986) Improved survival in squamous esophageal cancer. Arch. Surg. 121: 1330-1335.
162. Leichman, L., Herskovic, A., Leichman, C. G. et al. (1987) Nonoperative therapy for squamous-cell cancer of the esophagus. J. Clin. Oncol. 5: 365-370.
163. Poplin, E., Fleming, T., Leichman, L. et al. (1987) Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J. Clin. Oncol. 5: 622-628.
164. Coia, L. R., Engstrom, P. F. & Paul A. (1987) Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy. J. Clin. Oncol. 5: 1783-1790.
165. John, M., Flam, M., Wittlinger, P. & Ager Mowry, P. (1987) Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. Am. J. Clin. Oncol. 10: 310-316.
166. Richmond, J., Seydel, H. G., Bae, Y., Lewis, J., Burdakin, J. & Jacobsen, G. (1987) Comparison of three treatment strategies for esophageal cancer within a single institution. Int. J. Radiat. Oncol. Biol. Phys. 13: 1617-1620.
167. Kolaric, K., Nagy, B., Roth, A., Žu̧panc, D., Luetić, J. & Tometić, Z. (1988) Combined cis-platinum plus radiation antitumor activity in locoregionally advanced squamous cell esophageal cancer. Oncology 45: 276-280.
168. Seydel, H. G., Leichman, L., Byhardt, R. et al. (1988) Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: a RTOG study. Int. J. Radiat. Oncol. Biol. Phys. 14: 33-35.
169. MacFarlane, S. D., Hill, L. D., Jolly, P. C., Kozarek, R. A. & Anderson, R. P. (1988) Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation. J. Thorac. Cardiovasc. Surg. 95: 415-422.
170. Coia, L. R., Paul, A. R. & Engstrom, P. F. (1988) Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction. Cancer 61: 643-649.
171. Parker, E. F., Reed, C. E., Marks, R. D., Kratz, J. M. & Connolly, M. (1989) Chemotherapy, radiation therapy, and resection for carcinoma of the esophagus. J. Thorac. Cardiovasc. Surg. 98: 1037-1044.
172. John, M. J., Flam, M. S., Ager Mowry, P. A. et al. (1989) Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. Cancer 63: 2397-2403.
173. Chan, A., Wong, A. & Arthur, K. (1989) Concomitant 5-fluorouracil infusion mitomycin-C and radical radiation therapy in esophageal squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 16: 59-65.
174. Lackey, V. L., Reagan, M. T., Smith A. & Anderson, W. J. (1989) Neoadjuvant therapy of squamous cell carcinoma of the esophagus: role of resection and benefit in partial responders. Ann. Thorac. Surg. 48: 218-221.
175. Stewart, F. M., Harkins, B. J., Hahn, S. S. & Daniel, T. M. (1989) Cisplatin, 5-flourouracil, mitomycin-C, and concurrent radiation therapy with and without esophagectomy. Cancer 64: 622-628.
176. Seitz, J. F., Giovannini, M., Padaut-Cesana, J. et al. (1990) Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 66: 214-219.
177. Bidoli, P., Spinazze, S., Valente, M. et al. (1990) Combined chemotherapy-radiotherapy +/-esophagectomy in squamous cell cancer of the esophagus. Proc. Ann. Meet. Am. Soc. Clin. Oncol. 9: A424.
178. Araújo, C. M., Souhami, L., Gil, R. A. et al. (1991) A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67: 2258-2261.
179. Coia, L. R., Engstrom, P. F., Paul, A. R., Stafford, P. M. & Hanks, G. E. (1991) Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 20: 29-36.
180. Al-Sarraf, M., Martz, K., Herskovic, A. et al. (1996) Superiority of chemo-radiotherapy vs radiotherapy in patients with esophageal cancer. Final report of an Intergroup randomized and confirmed study. Proc. Ann. Meet Am. Soc. Clin. Oncol. 15: A464.
181. Gill, P. G., Denham, J. W., Jamieson, G. G., Devitt, P. G., Yeoh, E. & Olweny, C. (1992) Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J. Clin. Oncol. 10: 1037-1043.
182. Forastiere, A. A., Orringer, M. B., Perez-Tamayo, C., Urba, S. G. & Zahurak, M. (1993) Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J. Clin. Oncol. 11: 1118-1123.
183. Stewart, J. R., Hoff, S. J., Johnson, D. H. et al. (1993) Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann. Surg. 218: 571-578.
184. Naunheim, K. S., Petruska, P. J., Roy, T. S., Schlueter, J. M., Kim, H. & Baue, A. E. (1995) Multimodality therapy for adenocarcinoma of the esophagus. Ann. Thorac. Surg. 59: 1085-1091.
185. Bates, B. A., Detterbeck, F. C., Bernard, S. A., Qaqish, B. G. & Tepper, J. E. (1996) Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J. Clin. Oncol. 14: 156-163.
186. Hejna, M., Kornek, G. V., Schratter-Sehn, A. U. et al. (1996) Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Cancer 78: 1646-1650.
187. Walsh, T. N., Noonan N., Hollywood, D. et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. 335: 462-467.
188. Coia, L R., Soffen, E. M., Schultheiss, T. E., Martin, E. E. & Hanks, G. E. (1993) Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Cancer 711: 281-286.